Using participant skin cells reprogrammed into neurons, Weill Cornell Medicine researchers have identified genetic signatures ...
Researchers at UVA School of Medicine have found long-sought answers to questions about HIV transmission, and the findings could lead to new ways to prevent the disease’s spread. More than 1 million ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
The US government paused all foreign assistance in January 2025. This abrupt decision affected the delivery of life-saving ...
The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
Brazil's Health Regulatory Agency (Anvisa) approved on Monday the use of the drug Sunlenca (lenacapavir) for HIV-1 prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback